CenterWatch, the leading publication for clinical trials, has written about our work in Colombia

"Miami-based consultancy bringing more U.S. startups' phase I trials to Colombia." -CenterWatch Weekly, April 6, 2015

The above was the title of a recent front-page article that CenterWatch, the leading clinical research publication, has published profiling our work in Colombia. 

There are no words to describe our excitement over this article, and I decided to share it with all of you since your trust gives us the strength that is needed to overcome the challenges of conducting a successful trial overseas. 

Our organization, in alliance with the Government of Colombia, is committed to helping innovative medtech and biotech startups successfully conduct their early stage trials in Colombia. 

The combination of good healthcare (95% of Colombian citizens have health insurance), an already strong clinical trial industry, stringent regulations issued in 2008 that requires sites to be certified by INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) and a relatively quick and predictable approval process for launching a trial has made it a desirable clinical trial destination.” -Ronald Rosenberg, CenterWatch Weekly, April 6, 2015